ArticlePhytochemistry2025
Exploring evolutionary use of single residue switches for alternative product outcome in class II diterpene cyclases.
Article in Phytochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comprehensive genomic analysis reveals the class II diterpene cyclases in Dodonaea viscosa.Phytochemistry · 2026Article
- Peeking behind the carbocation: identification of (alternative) catalytic bases in the class II active site of conifer resin acid diterpene synthases.The Biochemical journal · 2026Article
- Investigating conserved aromatic residues in ent-copalyl pyrophosphate synthases required for gibberellin phytohormone biosynthesis.Phytochemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Class II diterpene cyclases (DTCs) define the widespread labdane-related diterpenoids. These are particularly prevalent in plants due to the requisite production of gibberellin (GA) phytohormones, specifically from gene duplication and neofunctionalization of the relevant DTC. Alteration of product outcome can be predicted/engineered to some extent by changes in the ancestral histidine-asparagine catalytic base dyad found in the ent-copalyl pyrophosphate (ent-CPP) synthases (CPSs) involved in GA biosynthesis. It has been shown such changes can switch product outcome in CPSs, with substitution of alanine for either leading to incorporation of water - i.e., production of 8α-hydroxy-ent-labda-13-en-15-yl pyrophosphate (ent-LPP), while replacing the histidine with tyrosine leads to production of a rearranged product - i.e., ent-kolavenyl pyrophosphate (ent-KPP). Indeed, native ent-KPP synthases from dicots with such substitution have been found, and restoration of the ancestral residue results in production of ent-CPP. Observation of a similar ent-KPP synthase and, strikingly, an ent-LPP synthase with serine in place of the asparagine, along with another DTC with such substitution but still producing ent-CPP, was recently made in non-seed plants. Here the role of these substitutions was examined by ancestral residue restoration. Notably, while this led to the production of ent-CPP in the first two concordant cases, in the latter incongruent DTC this had little effect. This presumably reflects extended adaptation, consistent with its more distant phylogenetic relationship to those from GA biosynthesis. This demonstrates both the utility but also limitations of the ability of changes to the ancestral catalytic base dyad to affect product outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.